Search the Newsreel

Avidity Biosciences Inc (RNA) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Avidity Biosciences Inc (RNA), detailing its price momentum score of 3.55 and market performance. It outlines key support and resistance levels, and presents a comprehensive overview of various technical indicators, including MACD, RSI, and moving averages, along …

ATRenew Inc (RERE) Cash Flow

This article provides a detailed cash flow statement for ATRenew Inc (RERE), including quarterly and annual data for operating, investing, and financing activities. It breaks down various components of cash flow such as net income, capital expenditures, and debt issuance/repayment, offering insights into the …

Aptargroup Inc (ATR) Institutional Confidence

Aptargroup Inc (ATR) has an institutional shareholding score of 7.00, placing it 15th out of 21 in the Containers & Packaging industry. The overall institutional shareholding proportion is 89.34%, marking a 10.52% decrease quarter-over-quarter. ETHSX is the largest institutional shareholder, holding 3.55 million shares, …

Aptargroup Inc (ATR) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Aptargroup Inc (ATR), noting its current score of 8.57 and ranking within the Containers & Packaging industry. It highlights the company's beta value of 0.40, indicating lower volatility compared to the S&P 500. The assessment also details …

PULM|Pulmatrix Inc|Price:1.670|Chg%:-0.060

This article provides a comprehensive stock analysis of Pulmatrix Inc (PULM) from TradingKey, highlighting its healthy fundamentals, high growth potential, and "fairly valued" status within the Biotechnology & Medical Research industry. It notes strong institutional ownership and a medium-term upward trend expectation for the …

BlackRock (RNA holder) discloses 6.6% Atrium Therapeutics stake in amended ownership filing

BlackRock, Inc. has filed an amended ownership report (SCHEDULE 13G/A) disclosing a 6.6% beneficial ownership stake in Atrium Therapeutics, Inc. This represents 1,135,757 shares of common stock, with BlackRock holding sole voting power over 1,119,668 shares and sole dispositive power over all beneficially owned …

Patriot National Bancorp Inc (PNBK) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Patriot National Bancorp Inc (PNBK), noting its current valuation score of 8.80 and ranking within the Banking Services industry. It highlights the company's P/E ratio of 38.91, comparing it to recent highs and lows. The analysis also …

Viatris Inc (VTRS) Income Statement

This article provides the quarterly and annual income statements for Viatris Inc (VTRS), offering detailed financial data such as total revenue, cost of revenue, operating expenses, operating profit, net income, and earnings per share (EPS). It includes year-over-year percentage changes and absolute figures across …

Viatris Inc (VTRS) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides a detailed breakdown of Viatris Inc.'s (VTRS) shareholder structure, listing major shareholders and their proportionate holdings, along with institutional ownership trends over recent quarters. It also categorizes shareholders by type and lists ETFs with significant VTRS holdings.

Aptar Named One of the World's Most Sustainable Companies by TIME for Third Consecutive Year

CRYSTAL LAKE, Ill., July 27, 2026--(BUSINESS WIRE)--AptarGroup, Inc. (NYSE: ATR), a global leader in drug delivery, dosing and protection technologies, and consumer product dispensing, today announced that it has been named one of the World's Most Sustainable Companies 2026 by TIME for the third …

Viatris stock hits 52-week high at $17.68

Viatris Inc. (VTRS) stock reached a 52-week high of $17.68, reflecting strong market performance with a 90.82% surge over the past year and a 2.78% dividend yield. The pharmaceutical company is considered undervalued by InvestingPro, with recent positive news including exceeding Q1 2026 financial …

Atreyu Capital Markets Ltd. Revenue Breakdown – TASE:ATRY

AtriCure, Inc. 2026: Revenue $153.6M, EPS $0.18— 10-Q Summary

AtriCure, Inc. reported its 2026 quarter results, showing a significant revenue increase to $153.6M, up 12.8% year-over-year. The company returned to net income with diluted EPS of $0.18, compared to a loss in the prior year. Growth was driven by strong U.S. demand and …

AtriCure, Inc. Quarterly Earnings Report

AtriCure, Inc. (ATRC) filed its Form 10-Q for the quarter ended June 30, 2026, reporting $167,786 thousand in cash and $61,000 thousand in debt. The company achieved $9,063 thousand in net income and $18,196 thousand in operating cash flow for the six months, a …

SNX vs. DT: Which Stock Is the Better Value Option?

Investors interested in Computers - IT Services stocks are likely familiar with TD SYNNEX (SNX) and Dynatrace (DT). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. We have …

Aptargroup Inc (ATR) Income Statement

YTRA|Yatra Online Inc|Price:0.911|Chg%:-0.024

YTRA|Yatra Online Inc|Price:0.870|Chg%:+0.020

Pulmatrix Inc (PULM) Cash Flow

This article provides a detailed cash flow statement for Pulmatrix Inc (PULM), covering quarterly and annual data from FY2013Q1 to FY2026Q1. It breaks down operating, investing, and financing cash flows, along with changes in working capital and net income from continuing operations. The document …

Patriot National Bancorp Inc (PNBK) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Patriot National Bancorp Inc (PNBK), listing major individual and corporate shareholders, their respective proportions, and historical institutional holdings. It provides a breakdown of shareholder types, including individual investors, corporations, and investment advisors, alongside recent changes in shareholder …

Patriot National Bancorp Inc (PNBK) Institutional Confidence

Patriot National Bancorp Inc (PNBK) has an institutional shareholding score of 3.00, placing it 250th out of 394 in the Banking Services industry. The institutional shareholding proportion is 19.10%, a 95.52% increase quarter-over-quarter. Steven Cohen is the largest institutional shareholder, holding 106.79K shares, while …

Dynatrace Inc (DT) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides details on Dynatrace Inc (DT) stock, including its current market price, market capitalization, and P/E ratio. It specifically notes that Dynatrace has distributed $0.00 in dividends over the past five years, indicating no historical dividend payouts for the company. The page …

AtriCure’s Profitability Inflection and 2026 Guidance Could Be A Game Changer For AtriCure (ATRC)

AtriCure, Inc. (ATRC) reported a significant profitability inflection in Q2 2026, moving from a net loss to positive earnings, achieving US$153.6 million in revenue and US$8.96 million in net income. The company issued full-year 2026 guidance forecasting US$602 million to US$610 million in revenue …

Dynatrace's Two Investor Conference Webcasts Archived for 30 Days

Dynatrace announced that its executives will present at two upcoming investor conferences: the KeyBanc Capital Markets Technology Leadership Forum on August 10 and the Goldman Sachs Communacopia & Technology Conference on September 9. Webcasts of both presentations will be available on the company's investor …

AtriCure to Participate at Upcoming Investor Conferences

MASON, Ohio, July 27, 2026--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, today announced that the company will be participating in two upcoming investor conferences. AtriCure's …

ATRC|AtriCure Inc|Price:35.040|Chg%:+2.040

This article provides a detailed company profile of AtriCure Inc (ATRC), a medical technology company specializing in treatments for atrial fibrillation, LAA management, and post-operative pain. It outlines the company's business scope, financial data including its market cap and revenue sources, and lists key …

Dynatrace Brings Autonomous Operations to Enterprise AI, Moving from Insight to Action

Dynatrace has introduced major advancements to its Intelligence platform, enabling autonomous operations for enterprise AI. These innovations, including new autonomous SRE agents and custom agent creation capabilities, help resolve incidents, prevent disruptions, and accelerate operations by grounding AI actions in deterministic, real-time understanding rather …

Dynatrace to Present at Upcoming Investor Conferences

Dynatrace (NYSE: DT) announced that its executives will present at two upcoming investor conferences: the KeyBanc Capital Markets Technology Leadership Forum on August 10 and the Goldman Sachs Communacopia & Technology Conference on September 9. Webcasts of these presentations will be available on the …

Atrium Mortgage Investment Corporation to Announce Q2 2026 Earnings and Host Investor Call

Seatrium shares close 8.9% higher after positive profit guidance

Avidity Biosciences Inc (RNA) Income Statement

This article provides the quarterly and annual income statement data for Avidity Biosciences Inc (RNA), detailing its financial performance including total revenue, operating expenses, net income, and earnings per share. It covers financial figures from FY2019Q1 up to FY2026Q1, allowing for an in-depth analysis …

AtriCure Inc (ATRC) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of AtriCure Inc (ATRC) regarding its dividend and stock split history. It states that no dividends have been distributed by the company over the past five years. The page also presents current stock performance data and market capitalization for …

Atrium Mortgage Investment Corp. Revenue Breakdown – TSX:AI

Medical device manufacturer gets a new backbone after global takeover

Chesterfield-based medical device manufacturer SpineCorporation has been acquired by the US healthcare company OrthoPediatrics Corp. The acquisition, supported by Hawsons Corporate Finance and Knights Solicitors, will expand OrthoPediatrics' presence in the specialist healthcare market. This cross-border deal marks a significant milestone for SpineCorporation, with …

Pulmatrix Inc (PULM) Institutional Confidence

Pulmatrix Inc (PULM) has an institutional shareholding score of 3.00, placing it 191st out of 384 companies in the Biotechnology & Medical Research industry. The institutional shareholding proportion has increased by 8.89% quarter-over-quarter, reaching 10.12%. James Simons is the largest institutional shareholder, holding 2.99% …

Viatris, Inc. Revenue Breakdown – BX:VTRS

Viatris, Inc. (VTRS) generated 11.34 billion CHF last year, with its "Brands" segment contributing the most at 7.28 billion CHF. The company's largest revenue contribution came from Developed Markets, accounting for 4.37 billion CHF. This data provides a snapshot of Viatris's key revenue drivers …